Model-Based Approach for Optimization of Atazanavir Dose Recommendations for HIV-Infected Pediatric Patients
Author:
Affiliation:
1. Discovery Medicine and Clinical Pharmacology, Bristol-Myers Squibb, Princeton, New Jersey
2. The Ann Arbor Pharmacometrics Group, Ann Arbor, Michigan
3. Global Clinical Research, Bristol-Myers Squibb, Wallingford, Connecticut
Abstract
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Link
https://journals.asm.org/doi/pdf/10.1128/AAC.00554-11
Reference21 articles.
1. Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics
2. BertzR.. 2007. Assessment of PK/PD relationships through 48 weeks from a study in HIV+, ARV-naïve subjects receiving antiretroviral regimens containing atazanavir 400 mg or atazanavir/ritonavir 300/100 mg once daily, poster 565. Abstr. 14th Conf. Retrovir. Opportunistic Infect., Los Angeles, CA.
3. Bristol-Myers Squibb. February 2011. Reyataz® (atazanavir sulfate) capsules: US prescribing information. Bristol-Myers Squibb Princeton NJ. http://packageinserts.bms.com/pi/pi_reyataz.pdf.
4. Bristol-Myers Squibb. 2011. Reyataz® (atazanavir sulfate) capsules: summary of product characteristics. Bristol-Myers Squibb Princeton NJ. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000494/WC500056380.pdf.
5. A Model-Based Approach to Dose Selection in Early Pediatric Development
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV;Therapeutic Drug Monitoring;2019-08
2. Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir;Pediatric Infectious Disease Journal;2018-06
3. Safety and Efficacy of Atazanavir Powder and Ritonavir in HIV-1-Infected Infants and Children From 3 Months to <11 Years of Age;Pediatric Infectious Disease Journal;2018-06
4. Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling and Simulation;The Journal of Clinical Pharmacology;2017-07-13
5. Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children;CPT: Pharmacometrics & Systems Pharmacology;2016-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3